Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

被引：0
|
作者：
Brevet, M. [1 ]
Arcila, M. [1 ]
Ladanyi, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1781
引用
收藏
页码：399A / 399A
页数：1
相关论文
共 50 条
  • [31] Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity
    Varella, Garcia Marileila
    Ladanyi, Marc
    Kris, Mark G.
    Rekhtman, Natasha
    Hirsch, Fred
    Miller, Vincent
    Riely, Gregory
    Pao, William
    Zakowski, Maureen F.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S341 - S341
  • [32] Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer
    Jiang, Guiyang
    Fan, Chuifeng
    Zhang, Xiupeng
    Dong, Qianze
    Wang, Liang
    Liu, Yang
    Dai, Shundong
    Yang, Lianhe
    Zhang, Yong
    Yu, Juanhan
    Wang, Enhua
    PLOS ONE, 2013, 8 (03):
  • [33] Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma
    Wen, Yong Hannah
    Brogi, Edi
    Hasanovic, Adnan
    Ladanyi, Marc
    Soslow, Robert A.
    Chitale, Dhananjay
    Shia, Jinru
    Moreira, Andre L.
    MODERN PATHOLOGY, 2013, 26 (09) : 1197 - 1203
  • [34] Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinoma and correlation with EGFR and KRAS mutation status and EGFR immunoreactivity
    Varella-Garcia, M.
    Ladanyi, M.
    Kris, M. G.
    Li, A.
    Chitale, D. A.
    Rekhtman, N.
    Riely, G. J.
    Miller, V. A.
    Hirsch, F. R.
    Zakowski, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Identification of EGFR Mutations by Immunohistochemistrv with EGFR Mutation Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
    Kim, Chi Hong
    Kim, Seung Hoon
    Park, Sonya Youngju
    Yoo, Jinyoung
    Kim, Sung Kyoung
    Kim, Hoon Kyo
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 653 - 660
  • [36] Comparison of the effect of two EGFR-TKI in patients with EGFR-mutant lung adenocarcinoma using in silico clinical trials
    Darre, Hippolyte
    Martin, Bastien
    Hammami, Firas
    Nativel, Arnaud
    Lefaudeux, Diane
    Toueg, Raphael
    Duruisseaux, Michael
    Palgen, Jean-Louis
    Masson, Perrine
    L'Hostis, Adele
    Ceres, Nicoletta
    Monteiro, Claudio
    CANCER RESEARCH, 2023, 83 (07)
  • [37] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Zohra Mraihi
    Jihen Ben Amar
    Hend Bouacha
    Soumaya Rammeh
    Lamia Hila
    BMC Pulmonary Medicine, 18
  • [38] Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
    Wang, Shuo
    Shi, Jingyun
    Ye, Zhaoxiang
    Dong, Di
    Yu, Dongdong
    Zhou, Mu
    Liu, Ying
    Gevaert, Olivier
    Wang, Kun
    Zhu, Yongbei
    Zhou, Hongyu
    Liu, Zhenyu
    Tian, Jie
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (03)
  • [39] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Mraihi, Zohra
    Ben Amar, Jihen
    Bouacha, Hend
    Rammeh, Soumaya
    Hila, Lamia
    BMC PULMONARY MEDICINE, 2018, 18
  • [40] Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma
    Weng, Luoqi
    Xu, Yilun
    Chen, Yuhan
    Chen, Chengshui
    Qian, Qinqing
    Pan, Jie
    Su, Huang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (06): : 1438 - 1445
12345